-
-
-
-
-
-
-
Sarepta Therapeutics (SRPT) Misses Q4 EPS by 237c
-
-
-
-
-
-
-
Sarepta Therapeutics Announces Third Quarter 2025 Financial Results and Recent Corporate Developments, Including Completion of Its Confirmatory Study, ESSENCE
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Sell Rating on Sarepta Therapeutics (SRPT)
-
-
-
-
-
-
-
H.C. Wainwright Upgrades Sarepta Therapeutics (SRPT) to Neutral
-
-
-
-
-
-
-
Sarepta Therapeutics Announces Third Quarter 2024 Financial Results and Recent Corporate Developments
-
-
-
-
-
-
-
Sarepta Therapeutics to Announce Second Quarter 2024 Financial Results
-
-
-
-
-
-
-
Sarepta Therapeutics (SRPT) Tops Q4 EPS by 84c
-
1,208,227 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

